Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed Central · Cited by 724

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 691

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 593

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four‐year prospective study from the Italian Registry

Finazzi, G., Brancaccio, V., Moia, M., Ciavarella, N., Mazzucconi, M. G., Schinco, P., Ruggeri, M., Pogliani, E. M., Gamba, G., Rossi, E., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00060-5 · Cited by 427

IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death

Levine, S. R., Salowich‐Palm, L., Sawaya, K. L., Perry, M., Spencer, H. J., Winkler, H. J., Alam, Z., & Carey, J. L. (1997) · Stroke · doi:10.1161/01.str.28.9.1660 · Cited by 212

Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies

Shamonki, J. M., Salmon, J. E., Hyjek, E. M., & Baergen, R. N. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.10.879 · Cited by 203

Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population

Shi, W., Krilis, S., Chong, B. H., Gordon, S., & Chesterman, C. N. (1990) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1990.tb01025.x · Cited by 196

Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations

Allegri, F., Sanmarco, M., Cinquini, M., Taglietti, M., Balestrieri, G., Koike, T., Ichikawa, K., Meroni, P. L., Boffa, M. C., & Tincani, A. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616089 · Cited by 182

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03674.x · Cited by 632

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

Devreese, K. M. J., Ortel, T. L., Pengo, V., & de Laat, B. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13976 · Cited by 269

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

Bertolaccini, M. L., Amengual, O., Andreoli, L., Atsumi, T., Chighizola, C. B., Forastiero, R., de Groot, P., Lakos, G., Lambert, M., Meroni, P., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.001 · Cited by 266

Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH

Devreese, K. M. J., Pierangeli, S. S., de Laat, B., Tripodi, A., Atsumi, T., & Ortel, T. L. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12537 · Cited by 224

International consensus guidelines on anticardiolipin and anti–β 2 ‐glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies

Lakos, G., Favaloro, E. J., Harris, E. N., Meroni, P. L., Tincani, A., Wong, R. C. W., & Pierangeli, S. S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33349 · Cited by 182

‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

Pierangeli, S., de Groot, P. G., Dlott, J. S., Favaloro, E. J., Harris, E., Lakos, G., Ortel, T. L., Meroni, P. L., Otomo, K., Pengo, V., et al. (2011) · Lupus · doi:10.1177/0961203310395055 · Cited by 179

Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

Meroni, P. L., Borghi, M. O., Grossi, C., Chighizola, C. B., Durigutto, P., & Tedesco, F. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0032-6 · Cited by 150

Diagnosis of antiphospholipid syndrome in routine clinical practice

Gardiner, C., Hills, J., Machin, S., & Cohen, H. (2013) · Lupus · doi:10.1177/0961203312460722 · Cited by 131

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies

Schreiber, K. I., Breen, K. A., Cohen, H., Jacobsen, S., Middeldorp, S., Pavord, S. R., Regan, L., Roccatello, D., Robinson, S. E., Sciascia, S., et al. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1603359 · Cited by 128

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Pengo, V., Ruffatti, A., Tonello, M., Cuffaro, S., Banzato, A., Bison, E., Denas, G., & Padayattil Jose, S. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12865 · Cited by 126

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

Tripodi, A., de Groot, P. G., & Pengo, V. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02362.x · Cited by 114

Antiphospholipid syndrome

Lim, W. (2013) · Hematology · doi:10.1182/asheducation-2013.1.675 · Cited by 107

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Pengo, V., Ruffatti, A., Del Ross, T., Tonello, M., Cuffaro, S., Hoxha, A., Banzato, A., Bison, E., Denas, G., Bracco, A., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12264 · Cited by 101

Antiphospholipid antibody testing and standardization

Devreese, K. M. J. (2014) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12234 · Cited by 98

Diagnosis and management of non-criteria obstetric antiphospholipid syndrome

Machin, S. J., Mackie, I. J., Cohen, H., & Arachchillage, D. J. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0416 · Cited by 97

Role of anti‐domain 1‐β2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome

Craemer, A. S. D., Musiał, J., & Devreese, K. M. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13389 · Cited by 78

EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies

Pregnolato, F., Gerosa, M., Raimondo, M. G., Comerio, C., Bartoli, F., Lonati, P. A., Borghi, M. O., Acaia, B., Ossola, M. W., Ferrazzi, E. M., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa203 · Cited by 76

High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome

Simchen, M. J., Dulitzki, M., Rofe, G., Shani, H., Langevitz, P., Schiff, E., & Pauzner, R. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01236.x · Cited by 72

Identification of high thrombotic risk triple‐positive antiphospholipid syndrome patients is dependent on anti‐cardiolipin and anti‐β2glycoprotein I antibody detection assays

Chayoua, W., Kelchtermans, H., Moore, G. W., Musiał, J., Wahl, D., de Laat, B., & Devreese, K. M. J. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14261 · Cited by 71

The treatment of anti-phospholipid syndrome: A comprehensive clinical approach

Chighizola, C. B., Andréoli, L., Gerosa, M., Tincani, A., Ruffatti, A., & Meroni, P. L. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.02.003 · Cited by 66

Correct laboratory approach to APS diagnosis and monitoring

Pengo, V., Banzato, A., Denas, G., Jose, S. P., Bison, E., Hoxha, A., & Ruffatti, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.11.008 · Cited by 62

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome

Hoxha, A., Mattia, E., Tonello, M., Grava, C., Pengo, V., & Ruffatti, A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0638 · Cited by 57

Antiphospholipid antibodies: Evaluation of the thrombotic risk

Devreese, K. M. J. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.270 · Cited by 56

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

Ruffatti, A., Favarò, M., Hoxha, A., Zambon, A., Marson, P., Ross, T. D., Calligaro, A., Tonello, M., & Nardelli, G. B. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.03.004 · Cited by 55

Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays

Vikerfors, A., Johansson, A.-B., Gustafsson, J. T., Jonsen, A., Leonard, D., Zickert, A., Nordmark, G., Sturfelt, G., Bengtsson, A., Ronnblom, L., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/kes252 · Cited by 51

Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms

Chayouâ, W., Kelchtermans, H., Moore, G. W., Gris, J., Musiał, J., Wahl, D. G., Zuily, S., Gianniello, F., Fontana, P., Remijn, J. A., et al. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1679901 · Cited by 51

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome

Devreese, K. M. J., Zuily, S., & Meroni, P. L. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100134 · Cited by 51

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome

Meneghel, L., Ruffatti, A., Gavasso, S., Tonello, M., Mattia, E., Spiezia, L., Tormene, D., Hoxha, A., Fedrigo, M., & Simioni, P. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.04.033 · Cited by 42

Antiphospholipid antibody profiling — Time for a new technical approach?

Roggenbuck, D., Egerer, K., von Landenberg, P., Hiemann, R., Feist, E., Burmester, G., & Dörner, T. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.016 · Cited by 41

Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab

Ruffatti, A., Tarzia, V., Fedrigo, M., Calligaro, A., Favarò, M., Macor, P., Tison, T., Cucchini, U., Cosmi, E., Tedesco, F., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.015 · Cited by 40

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers

Tonello, M., Mattia, E., Favarò, M., Ross, T. D., Calligaro, A., Salvan, E., Hoxha, A., Fedrigo, M., & Ruffatti, A. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.03.006 · Cited by 38

The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method

Meneghel, L., Ruffatti, A., Gavasso, S., Tonello, M., Mattia, E., Spiezia, L., Campello, E., Hoxha, A., Fedrigo, M., Punzi, L., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0925 · Cited by 37

Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome

Zhang, S., Wu, Z., Li, P., Bai, Y., Zhang, F., & Li, Y. (2015) · Medicine · doi:10.1097/md.0000000000002059 · Cited by 37

APS - Diagnostics and challenges for the future

Pengo, V., Bison, E., Zoppellaro, G., Jose, S. P., Denas, G., Hoxha, A., Ruffatti, A., & Banzato, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.028 · Cited by 37

Testing for antiphospholipid antibodies: Advances and best practices

Devreese, K. M. J. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13195 · Cited by 39

Antiphospholipid syndrome: critical analysis of the diagnostic path

Pengo, V., Banzato, A., Bison, E., Denas, G., Jose, S. P., & Ruffatti, A. (2010) · Lupus · doi:10.1177/0961203309360543 · Cited by 35

Laboratory Diagnostics of Antiphospholipid Syndrome

Bison, E., Denas, G., Jose, S., Zoppellaro, G., Banzato, A., & Pengo, V. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1601331 · Cited by 37

Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective

Pengo, V., & Denas, G. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.07.011 · Cited by 37

16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome

de Jesús, G. R., Benson, A. E., Chighizola, C. B., Sciascia, S., & Branch, D. W. (2020) · Lupus · doi:10.1177/0961203320954520 · Cited by 37

Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome

Hoxha, A., Ruffatti, A., Tonello, M., Bontadi, A., Salvan, E., Banzato, A., Pengo, V., & Punzi, L. (2012) · Lupus · doi:10.1177/0961203312441983 · Cited by 34

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification

Vanoverschelde, L., Kelchtermans, H., Musial, J., de Laat, B., & Devreese, K. M. J. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12207 · Cited by 33

Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome

Hoxha, A., Ruffatti, A., Mattia, E., Meneghel, L., Tonello, M., Salvan, E., Pengo, V., & Punzi, L. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1129 · Cited by 33

Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report

Ruffatti, A., Silvestro, G. D., Marson, P., Tonello, M., Calligaro, A., Favarò, M., Ross, T. D., Hoxha, A., Mattia, E., & Pengo, V. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.001 · Cited by 35

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study

Hoxha, A., Calligaro, A., Tonello, M., Ramonda, R., Carletto, A., Paolazzi, G., Bortolotti, R., Ross, T. D., Grava, C., Boaretto, M., et al. (2015) · Joint Bone Spine · doi:10.1016/j.jbspin.2015.04.020 · Cited by 29

Laboratory testing for antiphospholipid syndrome

Pengo, V., Banzato, A., Bison, E., Denas, G., Zoppellaro, G., Bracco, A., Jose, S. P., Hoxha, A., & Ruffatti, A. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12507 · Cited by 29

Diagnosis and therapy of antiphospholipid syndrome

Pengo, V., Denas, G., Jose, S. P., Zoppellaro, G., Bison, E., Banzato, A., Hoxha, A., & Ruffatti, A. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3051 · Cited by 28

Anti‐phospholipid antibodies and reproductive failures

Beltagy, A., Trespìdi, L., Gerosa, M., Ossola, M. W., Meroni, P. L., & Chighizola, C. B. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13258 · Cited by 28

APS – controversies in diagnosis and management, critical overview of current guidelines

Pengo, V. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70014-7 · Cited by 25

Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?

Tonello, M., Bison, E., Cattini, M. G., Pontara, E., Iaccarino, L., Denas, G., Cheng, C., & Pengo, V. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0692 · Cited by 25

Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome

Scambi, C., Ugolini, S., Tonello, M., Bortolami, O., Franceschi, L. D., Castagna, A., Lotti, V., Corbella, M., Raffaelli, R., Caramaschi, P., et al. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13185 · Cited by 23

Accuracy of the First Fully Automated Method for Anti‐cardiolipin and Anti‐β2 Glycoprotein I Antibody Detection for the Diagnosis of Antiphospholipid Syndrome

Villalta, D., Alessio, M. G., Tampoia, M., Re, A., Stella, S., Re, M., Tozzoli, R., & Bizzaro, N. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04659.x · Cited by 22

Management of pregnant women with antiphospholipid antibodies

Ruffatti, A., Favarò, M., Calligaro, A., Zambon, A., & Ross, T. D. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1565995 · Cited by 21

Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti‐beta2 glycoprotein‐1 antibodies

Fontana, P., Poncet, A., Lindhoff‐Last, E., de Moerloose, P., & Devreese, K. M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12732 · Cited by 19

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block

Ruffatti, A., Favarò, M., Brucato, A. L., Ramoni, V. L., Facchinetti, M., Tonello, M., Ross, T. D., Calligaro, A., Hoxha, A., Grava, C., et al. (2015) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2015.11.006 · Cited by 19

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review

da Rosa, G. P., Ferreira, E., Sousa‐Pinto, B., Rodríguez‐Pintó, I., Brito, I., Mota, A., Cervera, R., & Espinosa, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967178 · Cited by 18

The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome

Hoxha, A., Ruffatti, A., Pittoni, M., Bontadi, A., Tonello, M., Salvan, E., Plebani, M., & Punzi, L. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.02.004 · Cited by 17

A Clinical Approach for Defining the Threshold between Low and Medium Anti-Cardiolipin Antibody Levels for QUANTA Flash Assays

Lakos, G., Bentow, C., & Mähler, M. (2016) · Antibodies · doi:10.3390/antib5020014 · Cited by 17

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam, B. B., Cromar, A., Davis, K. W., & Tebo, A. E. (2012) · PubMed Central · Cited by 17

Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's

Arnaud, L., Conti, F., Massaro, L., Denas, G., Chasset, F., & Pengo, V. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.09.003 · Cited by 16

What’s new in obstetric antiphospholipid syndrome

Branch, D. W. (2019) · Hematology · doi:10.1182/hematology.2019000043 · Cited by 16

Antiphospholipid syndrome: interpretation of laboratory data

Pengo, V. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04151.x · Cited by 15

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

Tonello, M., Mattia, E., Ross, T. D., Favarò, M., Calligaro, A., Hoxha, A., Bison, E., Pengo, V., & Ruffatti, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.037 · Cited by 15

Index of circulating anticoagulant cut‐off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis

Kumano, O., Ieko, M., Naito, S., Yoshida, M., Takahashi, N., & Aoki, T. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12345 · Cited by 14

Antiphospholipid Syndrome: State of the Art of Clinical Management

Depietri, L., Veropalumbo, M. R., Leone, M. C., & Ghirarduzzi, A. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07496-3 · Cited by 16

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study

Hoxha, A., Favarò, M., Calligaro, A., Ross, T. D., Ruffatti, A. T., Infantolino, C., Tonello, M., Mattia, E., & Ruffatti, A. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1697665 · Cited by 14

The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics

Tonello, M., Calligaro, A., Favarò, M., Ross, T. D., Veronese, P., Salvan, E., Gervasi, M. T., & Ruffatti, A. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05766-1 · Cited by 14

Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines

Bor, M. V., Jacobsen, I.-L. S., Gram, J., & Sidelmann, J. J. (2018) · Lupus · doi:10.1177/0961203318776105 · Cited by 13

More on: the debate on antiphospholipid syndrome classification criteria

Swadźba, J., & Musiał, J. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03274.x · Cited by 13

Clinical profiles and risk assessment in patients with antiphospholipid antibodies

Kato, M., Hisada, R., & Atsumi, T. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1543025 · Cited by 13

Antiphospholipid antibodies and idiopathic infertility

Porto, F. D., Ferrero, S., Cifani, N., Sesti, G., & Proietta, M. (2022) · Lupus · doi:10.1177/09612033221076735 · Cited by 12

High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets

Ruffatti, A., Tonello, M., Calligaro, A., Ross, T. D., Favarò, M., Zen, M., Carletto, A., Lotti, V., Bertoldo, E., Tedesco, F., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/7cinzu · Cited by 13

Obstetric Antiphospholipid Syndrome: Lobsters Only? Or Should We Also Look for Selected Red Herrings?

Meroni, P. L., Chighizola, C. B., Gerosa, M., Trespìdi, L., & Acaia, B. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141407 · Cited by 12

Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays

Raby, A., Moffat, K. A., & Crowther, M. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-339-8_32 · Cited by 12

Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?

Calcaterra, I. L., Tufano, A., Lupoli, R., Iannuzzo, G., Emmi, G., & Minno, M. N. D. D. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15415 · Cited by 12

Antiphospholipid antibodies in critical illness

Dentali, F., & Crowther, M. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9e363 · Cited by 11

Clinical and laboratory characteristics of isolated lupus anticoagulants

Mattia, E., Tonello, M., Ross, T. D., Zerbinati, P., Campello, E., Simioni, P., & Ruffatti, A. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.03.008 · Cited by 10

Assessment of diagnostic methods for the detection of anticardiolipin and anti-βeta2 glycoprotein I antibodies in patients under routine evaluation for antiphospholipid syndrome

Martins, T. B., Heikal, N., Miller, J. W., Willis, R., Schmidt, R. L., & Tebo, A. E. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.008 · Cited by 9

Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines

da Rosa, G. P., Rodríguez‐Pintó, I., Cervera, R., & Espinosa, G. (2021) · Expert Review of Hematology · doi:10.1080/17474086.2021.1923474 · Cited by 9

Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review of the literature

Ruffatti, A., Tonello, M., Calligaro, A., Del Ross, T., Favaro, M., Zen, M., Hoxha, A., & Alaibac, M. (2023) · Clinical Rheumatology · doi:10.1007/s10067-023-06699-1 · Cited by 9

Interpretation of laboratory data and need for reference laboratories

Pengo, V., Denas, G., Banzato, A., Bison, E., Bracco, A., Visentin, M. S., Hoxha, A., & Ruffatti, A. (2012) · Lupus · doi:10.1177/0961203312437271 · Cited by 9

The Clinical Performance of a New Chemiluminescent Immunoassay in Measuring Anti-β2 Glycoprotein 1 and Anti-Cardiolipin Antibodies

Zhou, J., Hou, X., Zhang, H., Wang, T., & Cui, L. (2018) · Medical Science Monitor · doi:10.12659/msm.910369 · Cited by 8

Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancy

Gabbay‐Benziv, R., danieli, H. Z., Blickstein, D., Shmueli, A., Salman, L., & Hadar, E. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12511 · Cited by 8

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers

Calcaterra, I. L., Ambrosino, P., Vitelli, N., Lupoli, R., Orsini, R. C., Chiurazzi, M., Maniscalco, M., & Minno, M. N. D. D. (2021) · Biomedicines · doi:10.3390/biomedicines9020122 · Cited by 9

Solid Phase Immunoassay for the Detection of Anticardiolipin Antibodies

Willis, R., Papalardo, E., & Harris, E. N. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7196-1_16 · Cited by 8

Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS

Zen, M., Tonello, M., Carta, F., Calligaro, A., Favaro, M., Del Ross, T., Hulej, G., Rahmé, Z., Ruffatti, A., & Doria, A. (2025) · Rheumatology · doi:10.1093/rheumatology/keae665 · Cited by 7

A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay

Mattia, E., Ruffatti, A., Meneghel, L., Tonello, M., Faggian, D., Hoxha, A., Fedrigo, M., Punzi, L., & Plebani, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.04.012 · Cited by 7

Laboratory Evaluation of Antiphospholipid Syndrome

Tebo, A. E. (2019) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2019.07.004 · Cited by 7

Solid Phase Immunoassay for the Detection of Anti-β2 Glycoprotein I Antibodies

Willis, R., Papalardo, E., & Harris, E. N. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7196-1_17 · Cited by 7

Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?

Beça, S., Borrell, M., Cervera, R., Figueras, F., Nadal, A., Espinosa, G., & Baños, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041299 · Cited by 6

Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation

Zen, M., Tonello, M., Favarò, M., Ross, T. D., Calligaro, A., Giollo, A., Vesentini, F., Gennaio, I. A., Arru, F., Ruffatti, A., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead517 · Cited by 6

Does incomplete obstetric antiphospholipid syndrome really exist?

Alijotas‐Reig, J. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2020.12.023 · Cited by 6

Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency Testing Program

Tebo, A. E., Rohan, W., Nwosu, A., Bashleben, C. P., Fox, D. A., Linden, M. A., & Karlon, W. J. (2023) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2023-0095-cp · Cited by 5

Diagnóstico en el síndrome antifosfolipídico: desde una perspectiva histórica a la aparición de nuevos autoanticuerpos

Ardila-Suarez, O., Gómez-Puerta, J. A., & Khamashta, M. A. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.01.005 · Cited by 5

Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

Olivieri, S., Ruffatti, A., Bontadi, A., Cavazzana, A., Salvan, E., Cuffaro, S., Giunco, S., & Punzi, L. (2011) · Reumatismo · doi:10.4081/reumatismo.2010.107 · Cited by 5

Definition and significance of high positivity aCL ELISA

Wahl, D. G., Devignes, J., Mohamed, S., Zuily, S., & Lecompte, T. (2012) · Lupus · doi:10.1177/0961203312443298 · Cited by 5

Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical Profile

Cabrera-Marante, Ó., Garcinuño, S., Pleguezuelo, D. E., Gil‐Etayo, F. J., Tenica, I., de Frías, E. R., Zafra, D., Castro, N., Paz‐Artal, E., Serrano, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417373 · Cited by 4

Antiphospholipid syndrome classification criteria: comments on the letter of Swadzba and Musial

Ruffatti, A., & Pengo, V. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03277.x · Cited by 4

Automated, semi‐automated, and manual analyses of anti‐cardiolipin and anti‐β2‐glycoprotein I antibodies in women with a history of miscarriage

Gutensohn, K., Vossen, D., Strate, A., Kersten, J. F., Hofbauer, M., & Krieger, T. (2012) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12011 · Cited by 4

Risk and triggering factors for diffuse alveolar hemorrhage in primary antiphospholipid syndrome. An observational follow-up study and a systematic review of the literature

Ruffatti, A., Tonello, M., Favarò, M., Ross, T. D., Calligaro, A., Hoxha, A., Peronato, G., Facchini, C., Zen, M., & Manara, R. (2025) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2025.152697 · Cited by 3

A glimpse into the history of description of the antiphospholipid syndrome

Nour‐Eldine, W., Noureldine, H. A., Haydar, B. A., Eldine, M. N., Noureldine, M. H. A., & Uthman, I. W. (2020) · Lupus · doi:10.1177/0961203320947152 · Cited by 3

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification

Vanoverschelde, L., Kelchtermans, H., Musial, J., de Laat, B., & Devreese, K. M. J. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12207 · Cited by 33

Antiphospholipid syndrome classification criteria: comments on the letter of Swadzba and Musial

Ruffatti, A., & Pengo, V. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03277.x · Cited by 4

More on: the debate on antiphospholipid syndrome classification criteria

Swadźba, J., & Musiał, J. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03274.x · Cited by 13

Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays

Devreese, K. M. J., & Van Hoecke, F. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.06.023 · Cited by 32

The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies

Nash, M. J., Camilleri, R. S., Kunka, S., Mackie, I. J., Machin, S. J., & Cohen, H. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00810.x · Cited by 64